Most Michigan entrepreneurs and investors overlook a hidden gem—an innovative medical device company that’s transforming cancer treatment with ultrasound technology. Jim Adox, managing partner at Clarevia, reveals how a 16-year journey, massive capital infusions, and a bold strategic shift are now positioning Histosonics as a potential game-changer—and making waves in healthcare and venture capital right here in Michigan.

In this episode, Jim shares the remarkable story behind Histosonics: a university spin-off whose ultrasound platform not only targets tumors non-invasively but also offers patients a better quality of life—fewer side effects, faster recoveries, and a new lease on life. Jim walks through how this strategic move provides the flexibility for rapid multiorgan expansion, positioning Histosonics for future success.

You'll also get a behind-the-scenes look at the evolution of Michigan’s venture ecosystem, from Jim’s early engineering days to his role leading a dedicated life sciences fund. We break down the vital role Michigan’s universities play in fueling innovation, the capital gap that challenges scaling high-growth startups, and what it truly takes to keep world-class companies in-state.

Perfect for early-stage entrepreneurs, venture capitalists, or anyone passionate about Michigan’s innovation landscape—this conversation offers actionable advice: work hard, take risks, and find mentors who push you further. Jim’s story exemplifies perseverance and strategic vision, illustrating how bold moves and unwavering belief can turn scientific breakthroughs into global healthcare solutions.